Search research articles
Contact Us
Filters
Showing results (21-30 of 62) with videos related to
Page
of 7
Sort By:
Amino Acids
|
November 27, 2014
Evaluation of 99mTc-Z IGF1R:4551-GGGC affibody molecule, a new probe for imaging of insulin-like growth factor type 1 receptor expression
Bogdan Mitran, Mohamed Altai, Camilla Hofström, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 3, 2017
Radionuclide Tumor Targeting Using ADAPT Scaffold Proteins: Aspects of Label Positioning and Residualizing Properties of the Label
Sarah Lindbo, Javad Garousi, Bogdan Mitran, et al.
Bioconjugate Chemistry
|
May 28, 2013
Influence of nuclides and chelators on imaging using affibody molecules: comparative evaluation of recombinant affibody molecules site-specifically labeled with ⁶⁸Ga and ¹¹¹In via maleimido derivatives of DOTA and NODAGA
Mohamed Altai, Joanna Strand, Daniel Rosik, et al.
Pharmaceutics
|
April 23, 2022
Hematological Toxicity in Mice after High Activity Injections of <sup>177</sup>Lu-PSMA-617
Amanda Kristiansson, Oskar Vilhelmsson Timmermand, Mohamed Altai, et al.
Acta Diabetologica
|
October 25, 2017
Pancreatic imaging using an antibody fragment targeting the zinc transporter type 8: a direct comparison with radio-iodinated Exendin-4
Olof Eriksson, Olle Korsgren, Ram Kumar Selvaraju, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 16, 2011
Direct comparison of 111In-labelled two-helix and three-helix Affibody molecules for in vivo molecular imaging
Daniel Rosik, Anna Orlova, Jennie Malmberg, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
September 3, 2018
Affibody-derived drug conjugates: Potent cytotoxic molecules for treatment of HER2 over-expressing tumors
Mohamed Altai, Hao Liu, Haozhong Ding, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
January 18, 2012
Evaluation of a HER2-targeting affibody molecule combining an N-terminal HEHEHE-tag with a GGGC chelator for 99mTc-labelling at the C terminus
Hanna Lindberg, Camilla Hofström, Mohamed Altai, et al.
International Journal of Oncology
|
June 11, 2019
Potent and specific fusion toxins consisting of a HER2‑binding, ABD‑derived affinity protein, fused to truncated versions of Pseudomonas exotoxin A
Hao Liu, Sarah Lindbo, Haozhong Ding, et al.
Bioconjugate Chemistry
|
October 15, 2016
Influence of the N-Terminal Composition on Targeting Properties of Radiometal-Labeled Anti-HER2 Scaffold Protein ADAPT6
Javad Garousi, Sarah Lindbo, Hadis Honarvar, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 62) with videos related to
Sort By:
Page
of 7
Amino Acids
|
November 27, 2014
Evaluation of 99mTc-Z IGF1R:4551-GGGC affibody molecule, a new probe for imaging of insulin-like growth factor type 1 receptor expression
Bogdan Mitran, Mohamed Altai, Camilla Hofström, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 3, 2017
Radionuclide Tumor Targeting Using ADAPT Scaffold Proteins: Aspects of Label Positioning and Residualizing Properties of the Label
Sarah Lindbo, Javad Garousi, Bogdan Mitran, et al.
Bioconjugate Chemistry
|
May 28, 2013
Influence of nuclides and chelators on imaging using affibody molecules: comparative evaluation of recombinant affibody molecules site-specifically labeled with ⁶⁸Ga and ¹¹¹In via maleimido derivatives of DOTA and NODAGA
Mohamed Altai, Joanna Strand, Daniel Rosik, et al.
Pharmaceutics
|
April 23, 2022
Hematological Toxicity in Mice after High Activity Injections of <sup>177</sup>Lu-PSMA-617
Amanda Kristiansson, Oskar Vilhelmsson Timmermand, Mohamed Altai, et al.
Acta Diabetologica
|
October 25, 2017
Pancreatic imaging using an antibody fragment targeting the zinc transporter type 8: a direct comparison with radio-iodinated Exendin-4
Olof Eriksson, Olle Korsgren, Ram Kumar Selvaraju, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 16, 2011
Direct comparison of 111In-labelled two-helix and three-helix Affibody molecules for in vivo molecular imaging
Daniel Rosik, Anna Orlova, Jennie Malmberg, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
September 3, 2018
Affibody-derived drug conjugates: Potent cytotoxic molecules for treatment of HER2 over-expressing tumors
Mohamed Altai, Hao Liu, Haozhong Ding, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
January 18, 2012
Evaluation of a HER2-targeting affibody molecule combining an N-terminal HEHEHE-tag with a GGGC chelator for 99mTc-labelling at the C terminus
Hanna Lindberg, Camilla Hofström, Mohamed Altai, et al.
International Journal of Oncology
|
June 11, 2019
Potent and specific fusion toxins consisting of a HER2‑binding, ABD‑derived affinity protein, fused to truncated versions of Pseudomonas exotoxin A
Hao Liu, Sarah Lindbo, Haozhong Ding, et al.
Bioconjugate Chemistry
|
October 15, 2016
Influence of the N-Terminal Composition on Targeting Properties of Radiometal-Labeled Anti-HER2 Scaffold Protein ADAPT6
Javad Garousi, Sarah Lindbo, Hadis Honarvar, et al.
Page
of 7